Evaluation of efficay of topical tetracycline in enhancing the effect of phototherapy against vitiligo

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201108017160N3

Enrollment

Registered

2013-07-01

Start date

2013-06-18

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo.

Interventions

patients randomly apply tetracycline ointment twice daily on one lesion and placebo(yellow vaseline) on the other while taking phototherapy 2-3 times weekly.then according to photos taken and vasi sc

Treatment - Drugs

Eligibility

Sex/Gender

All

Age

8 Years to 70 Years

Inclusion criteria

Inclusion criteria: 30 patients with generalized stable vitiligo(more than 20% of body surface area) are chosen. Pregnant or lactating women and children under 8 years old are eliminated from the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Lesion pigmentation. Timepoint: Monthly. Method of measurement: Photo and VASI score.	—

Secondary

Measure	Time frame
Erythema. Timepoint: Monthly. Method of measurement: Photo.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Kalafi

Shiraz University of Medical Sciences

amirkalafi@yahoo.com+98 71 1231 9049

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026